Cannabinoid-Primed VR Therapy for PTSD and Sensory Response

The patent combines multiple therapeutic modalities including cannabinoid administration, VR/AR experiences, EFT (Emotional Freedom Techniques), and EMDR (Eye Movement Desensitization and Reprocessing) into an integrated treatment system. This merging of previously separate therapeutic approaches creates a synergistic effect that enhances both sensory stimulation and therapeutic effectiveness for treating mental health conditions.

The invention creates a composite therapeutic experience by layering multiple intervention types (pharmacological, technological, and psychotherapeutic) that work together. The cannabinoid compounds modify neural processing, while VR/AR provides controlled sensory input, and EFT/EMDR techniques address emotional processing, forming a multi-component therapeutic composite.

The patent implements a structured protocol where cannabinoid administration occurs before the VR/AR experience to prime the neural system, followed by controlled sensory stimulation during the experience, and then EFT/EMDR techniques afterward. This preliminary preparation and sequential organization of interventions reduces the perceived complexity by establishing clear temporal boundaries and preparation steps.

The system incorporates monitoring and adjustment mechanisms where the effects of cannabinoid administration and VR/AR exposure are assessed, and subsequent EFT/EMDR techniques are tailored based on the observed responses. This feedback loop allows the protocol to adapt to individual patient needs, making the complex multi-component system more manageable and effective.